Clinical Trial Update: Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of individually tailored prophylaxis with human-cl rhFVIII for severe haemophilia A has completed with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• human-cl rhFVIII (recombinant factor VIII concentrate (human-cl rhFVIII))

Snippet

Sponsor: Octapharma | Conditions: Severe Haemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2018-01-30